Global Market Quick Take: Asia – January 11, 2024

Global Market Quick Take: Asia – January 11, 2024

Macro 5 minutes to read
Saxo Be Invested
APAC Research

Summary:  The Japanese Yen experienced steep declines, with USDJPY reaching 145.83, nearing a test of 146. Notable movements occurred in crosses, with EURJPY testing 160, the highest since December. The Nasdaq 100 and S&P 500 approached record highs at 16,793 and 4,783, respectively. Meta surged 3.7% post a positive analyst report. The SEC approved spot bitcoin ETFs. Focus turns to the US CPI report today and the start of the US earnings season, featuring leading U.S. banks tomorrow.


Saxo’s Q1 2024 Outlook titled “What happened to the future” is now out. You can read it here.

The Saxo Quick Take is a short, distilled opinion on financial markets with references to key news and events. 

US Equities: The Nasdaq 100 Index climbed 0.7% to 16,793, and the S&P 500 Index added 0.6% to 4,783, both just a touch shy of record highs. Meta rose 3.7% after a favorable analyst report. Nvidia gained 2.3%, and Microsoft was 1.9% higher. The SEC approved several spot bitcoin ETFs for the first time for trade starting Thursday. These approved ETFs include ARK 21Shares Bitcoin ETF, Bitwise Bitcoin ETF, Blackrock’s iShares Bitcoin Trust, Hashdex Bitcoin ETF, Fidelity Wise Origin Bitcoin Fund, Franklin Bitcoin ETF, Grayscale Bitcoin Trust GBTC, Invesco Galaxy Bitcoin ETF, Valkyrie Bitcoin Fund, VanEck Bitcoin Trust, and WisdomTree Bitcoin Fund. Eyes are now on the CPI report later today and the kickoff of the earnings season with leading U.S. banks reporting tomorrow.

Fixed income: Ahead of the CPI data on Thursday, Treasuries were steady. The 2-year yield ticked down 1bp to 4.36%, while the 10-year yield edged up 2bps to 4.03%. The money market is pricing in an approximately 70% chance of a 25bp rate cut at the March FOMC. Increasing discussion among traders about the timing of a slowdown or end to quantitative tightening has also increased. For more information, see this Saxo article.

China/HK Equities: The Hang Seng Index declined for the seventh consecutive day, falling 0.6% on Wednesday. The weakness was across the board, with notable underperformance in auto names. Pharmaceutical stocks bucked the market decline, seeing some gains. The CSI300 shed 0.5% while healthcare and solar outperformed. In anticipation of monetary easing, deflation, and sluggish economic growth, the Chinese 10-year government bond yield fell below 2.5% to close at 2.49%. At the CES consumer electronics show in Las Vegas, Xpeng announced that it will begin accepting orders for its flying cars later this year, with deliveries scheduled for late 2025.

FX: The dollar was mostly sideways ahead of the US CPI data scheduled for release today, however steep declines seen in the Japanese yen again. USDJPY rose to highs of 145.83, approaching a test of 146 which has held up last week and also for much of December. Bigger moves however seen on the crosses, with EURJPY testing 160, the highest levels since the start of December, and GBPJPY just shy of 186. EUR strength was also broad, and EURUSD surged above 1.0970 and 1.10 remains on watch. AUDUSD stuck around 0.67 despite the miss in Nov CPI yesterday, while kiwi slipped. Bitcoin was back in the spotlight following the SEC approval of ETFs, and XBTUSD now trades above 46,500 after an initial gain to over 47,500.

Commodities: Crude oil traded lower after the EIA reported a surprise 1.3m barrels stock build driven by a 2m b/d export slump, coming in contrast to API data that had shown inventory drawdown. Supply concerns also however accelerated with Houthi rebels escalating attacks. Gold struggled to keep its gains and reversed after touching $2,040, slipping back lower to sub-$2,030 levels.

Macro: Fed’s John Williams (voter) said that monetary policy is tight enough to nudge inflation down to the Fed’s 2% goal but policymakers need more evidence before they can “dial back” interest rates. He noted that risks to the economy are two sided, and rate decisions will be made meeting-by-meeting and driven by the totality of data. The NY Fed President sees 2024 GDP at around 1.25% (beneath Fed median Dec SEP of 1.4%), 2024 unemployment at 4% (beneath Fed median of 4.1%), 2024 inflation at 2.25% (beneath Fed median of 2.4%) and 2% in 2025 (beneath Fed median of 2.1%).

Macro events: US CPI (Dec) – preview here, US Jobless Claims, US Budget (Dec), Italy Industrial Production (Nov), Spain Industrial Production (Nov), Japan Regional Economic Report (Jan), Japan Economic Coincident Index (Nov).

Earnings: Infosys, Tesco, Marks & Spencer, Fast Retailing, Seven I, Largan Precision, Tata Consultancy

In the news:

  • US SEC approves bitcoin ETFs in watershed for crypto market (Reuters)
  • BlackRock, Ark lower fee for planned spot bitcoin ETFs  (Reuters)
  • Nikkei 225 hits highest since Japan's 1990 bubble economy era (Japan Times)
  • US, UK forces repel 'largest attack' by Houthis in Red Sea (Reuters)
  • China Tensions Dominate Taiwan Election as Voters Head to Polls (Bloomberg)
  • Focus: At CES, legacy automakers scramble to keep up in AI arms race (Reuters)
  • Xpeng to deliver flying cars 'in 2025' as China aims to lead in rule-setting (Nikkei Asia)

For all macro, earnings, and dividend events check Saxo’s calendar.

For a global look at markets – go to Inspiration.


 

 

 

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992